ID   LS14
AC   CVCL_DH87
DR   cancercelllines; CVCL_DH87
DR   GEO; GSM482561
DR   Progenetix; CVCL_DH87
DR   Wikidata; Q54903050
RX   PubMed=16195405;
RX   PubMed=17426441;
WW   Provider; UC 1819 Innovation Hub; 106025; https://web.archive.org/web/20160818055736/http://www.ipo.uc.edu/index.cfm?fuseaction=technologies.results&item_number=106025
CC   Characteristics: Exhibits a gene expression pattern similar to that in primary preadipocytes and are capable of terminal differentiation. Can be considered as partially-differentiated preadipocytes that can be induce to terminally differentiate and accumulate lipid droplets following incubation in serum-free medium which contains a combination of adipogenic-inducing compounds (PubMed=16195405).
CC   Doubling time: ~96 hours (PubMed=16195405).
CC   Cell type: Preadipocyte; CL=CL_0002334.
DI   NCIt; C3194; Liposarcoma
DI   ORDO; Orphanet_69078; Liposarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
RX   PubMed=16195405; DOI=10.1210/en.2005-0989;
RA   Hugo E.R., Brandebourg T.D., Comstock C.E.S., Gersin K.S., Sussman J.J.,
RA   Ben-Jonathan N.;
RT   "LS14: a novel human adipocyte cell line that produces prolactin.";
RL   Endocrinology 147:306-313(2006).
//
RX   PubMed=17426441; DOI=10.4161/cbt.6.4.3816;
RA   LaPensee E.W., Reddy S.P., Hugo E.R., Schwemberger S.J.,
RA   Ben-Jonathan N.;
RT   "LS14 cells: a model for chemoresistance in liposarcoma.";
RL   Cancer Biol. Ther. 6:519-524(2007).
//